enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Novo eyes other health benefits from weight-loss drug Wegovy ...

   www.aol.com/news/novo-eyes-other-health-benefits...

   Further analysis of the results from the five-year trial, which included more than 17,000 patients, may also reveal more health benefits in areas such as kidney disease, heart failure and risk of ...

3. What to Eat (& Not to Eat) When Taking Wegovy for Weight Loss

   www.aol.com/eat-not-eat-taking-wegovy-115700840.html

   If you eat dairy, choose low-fat options for your Wegovy diet plan. Some low-fat dairy products: Cottage cheese. Low-fat or fat-free milk. Low-fat cheese. Low-fat yogurt. Greek yogurt. Plain, low ...

4. Wegovy Is Good for More Than Just Weight Loss - AOL

   www.aol.com/wegovy-good-more-just-weight...

   Obesity is a major risk factor for heart disease, and while doctors have an arsenal of medications to treat many other risk factors—such as high blood pressure, high cholesterol, and diabetes ...

5. Semaglutide - Wikipedia

   en.wikipedia.org/wiki/Semaglutide

   [24] [13] [14] [15] It is sold under the brand names Ozempic [13] and Rybelsus [14] for diabetes, and under the brand name Wegovy for weight loss. [ 15 ] Semaglutide is a glucagon-like peptide-1 receptor agonist .

6. Wegovy users keep weight off for four years, Novo Nordisk ...

   www.aol.com/news/wegovy-weight-loss-sustained...

   Wegovy and Zepbound are being tested to assess their benefits in a variety of other medical uses such as lowering heart attack risk and for sleep apnea and kidney disease.

7. Obesity drug Wegovy is approved to cut heart attack and ...

   www.aol.com/news/obesity-drug-wegovy-approved...

   Wegovy is a higher-dose version of Ozempic, the diabetes treatment that was previously approved to cut the risk of serious heart problems in people with that disease. The weight-loss drug ...

8. Is oral semaglutide a promising alternative in treating ... - AOL

   www.aol.com/lifestyle/oral-semaglutide-promising...

   For Wegovy, it is 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg per week, increased in the same manner. The participants in the new study were given daily oral prescriptions of 3 mg before being ...

9. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 agonists were developed initially for type 2 diabetes. [5] The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include GLP-1 agonist or SGLT2 inhibitor as a first line pharmacological therapy for type 2 diabetes in patients who have or are at high risk for atherosclerotic cardiovascular disease or heart failure.